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Abstract: There is growing evidence that depression increases the risk of incident stroke. 
However, few studies have considered possible residual confounding effects by preexistent 
cerebrovascular and cardiac diseases. Therefore, we synthesized data from cohort studies to 
explore whether depressed individuals free of cerebrovascular and cardiac diseases are at higher 
risk of incident stroke. We searched the electronic databases PubMed and Medline for eligible 
cohort studies that examined the prospective association between depression and first-ever stroke. 
A random-effects model was used for quantitative data synthesis. Sensitivity analyses comprised 
cohort studies that considered a lag period with exclusion of incident strokes in the first years of 
follow-up to minimize residual confounding by preexistent silent strokes and excluded cardiac 
disease at baseline. Overall, we identified 28 cohort studies with 681,139 participants and 13,436 
(1.97%) incident stroke cases. The pooled risk estimate revealed an increased risk of incident 
stroke for depression (relative risk 1.40, 95% confidence interval [CI] 1.27–1.53; P,0.0001). 
When we excluded incident strokes that occurred in the first years of follow-up, the prospective 
association between depression and incident stroke remained significant (relative risk 1.64, 95% 
CI 1.27–2.11; P,0.0001). This positive association also remained after we considered only 
studies with individuals with cardiac disease at baseline excluded (relative risk 1.43, 95% CI 
1.19–1.72; P,0.0001). The prospective association of depression and increased risk of first-
ever stroke demonstrated in this meta-analysis appears to be driven neither by preexistence of 
clinically apparent cerebrovascular and cardiovascular diseases nor by silent stroke.
Keywords: stroke, prestroke, depression, risk factor
Introduction
While for many years, supported by the results of two recent high-quality meta-analyses, 
it has been assumed that depression constitutes a possible risk factor for stroke, the 
previous hypothetic concept of “vascular depression” is fueling a new debate in the 
scientific community.1–3 The theory is that the presence of subclinical cerebrovascular 
diseases may induce neurobiological changes in brain regions, including the dorsal 
cortex and limbic structures, and therewith predispose, precipitate, or perpetuate 
depressive syndromes and at the same time occurrence of stroke.3 The findings of a 
recent large-scale cohort study including more than 10,000 people further substanti-
ate this hypothesis, when no association between depression and incident stroke was 
evident after considering only cerebrovascular events that occurred beyond the first 
years of follow-up.4 The latter approach may ensure that results are not biased by the 
fact that people who have had a clinically silent or apparent stroke immediately prior 
to study initiation have a higher risk of developing depression in the short term (ie, 
reverse causality).5
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To date, a large portion of all conducted cohort studies 
have not focused on stroke-free participants as the target 
population. For instance, the meta-analysis by Pan et al iden-
tified seven of 28 included studies that enrolled people with 
a history of stroke, increasing the chance that the findings 
were biased by reverse causality.2 Less attention has been 
given to other vascular comorbidities like cardiac disease 
in this matter. Apart from the probable causal relationship 
with cardiac disease causing depression and vice versa, it is a 
well-known fact that patients with cardiac disease have more 
than twice the odds of having a stroke than those without 
cardiac diasese.6–8 Moreover, these patients generally have 
a higher burden of vascular risk factors potentiating the 
manifestation of subclinical cerebrovascular disease that in 
turn may increase the possibility of residual confounding in 
longitudinal cohort studies.9
Since recently published reviews and meta-analyses, 
results of other longitudinal cohort studies investigating the 
prospective association between depression and incident 
stroke have been published. Modified inclusion criteria 
derived from conclusions and recommendations of previous 
research have been implemented to minimize study heteroge-
neity and biases, and now allow more in-depth conclusions 
on the potential risk-factor association between depression 
and stroke. Therefore, we aimed to update and enlarge the 
earlier knowledge base on the risk of a first-ever stroke in 
people with depression compared to people without depres-
sion by performing a systematic review and meta-analysis 
of cohort studies. We particularly explored the question of 
whether people with depression and free of both cerebro-
vascular and cardiac diseases are at higher risk of incident 
stroke or whether such association might rather result from 
reverse causality.
Materials and methods
literature search and study selection
We performed a systematic literature search using the 
PubMed and Medline electronic databases. The text words 
“depression” and “stroke” with the use of the Boolean 
operator “AND” were used to identify relevant studies that 
examined the prospective association between depression and 
incident stroke. We exclusively chose these two text words 
and their corresponding MeSH (Medical Subject Heading) 
terms (“depressive disorder” OR “depressive” AND “disor-
der” OR “depressive disorder” OR “depression” OR “depres-
sion” AND “stroke”) to ensure coverage of all potentially 
eligible articles stored in the searched electronic databases. In 
addition, we manually searched the bibliographies of recently 
published opinion statements, reviews, and meta-analyses 
that addressed the risk-factor association between depression 
and stroke to identify further articles of interest.1,2,10,11 We 
only considered articles published in the English language 
for further review and excluded duplicates.
The title and abstract of the identified articles were 
screened according to the eligibility criteria detailed in the 
next section by an independent reviewer (KB). Full texts were 
retrieved and reviewed for definite eligibility. Any ambigui-
ties concerning the eligibility of a full text were discussed 
with a second independent investigator (JK) to reach a final 
consensus. In the case of missing information or any obscuri-
ties, the lead authors of the identified articles were contacted 
for clarification. The literature search covered studies from 
the earliest date available until our last search on August 24, 
2014. Our systematic review and meta-analysis complied 
with the Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses (PRISMA) guidelines.12
eligibility criteria
According to our formulated PICOS (participants, interven-
tions, comparators, outcomes, and study design) question,12 
an original epidemiological study was included if 1) partici-
pants were nonhospitalized adults with no history of stroke 
or transient ischemic attack (TIA) at the time of study ini-
tiation, 2) the exposure (intervention) variable was defined 
as depression, whereas assessment of depression had to 
be prospectively performed at baseline and based upon an 
objective measure like a neuropsychological mood scale or 
neuropsychiatric evaluation that complied with the Diagnos-
tic Statistical Manual for Mental Disorders (DSM)-III/IV 
or the International Classification of Diseases (ICD)-7–10, 
3) the comparison group consisted of participants without 
depression at the time of study initiation, 4) the dichotomous 
outcome event of interest was a first-ever stroke during the 
follow-up period, including fatal and nonfatal ischemic stroke, 
TIA, and intracerebral hemorrhage (hereinafter referred as 
“all stroke”), and 5) the study design was a community-, 
population-, or registry-based longitudinal cohort study 
reporting relative effect estimates, such as hazard ratios 
(HRs), relative risk (RRs), and odds ratios (ORs).
Data items
The following data items were extracted from the included 
original full-text articles and entered into a predetermined 
Excel (Microsoft, Redmond, WA, USA) spreadsheet: 1) arti-
cle information (name of first author, publication year, jour-
nal), 2) study design (population-level, study geographical 
location, length of follow-up, methods used for assessment 
of the exposure [eg, applied mood scale, neuropsychiatric Neuropsychiatric Disease and Treatment 2015:11 submit your manuscript | www.dovepress.com
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face-to-face evaluation] and outcome measures [eg, review 
of hospital discharge records, death certificates], cohort size, 
variables included in the final adjusted model), 3) results 
(population characteristics including age and sex, number 
of incident cases registered during follow-up in the exposed 
and unexposed participants, adjusted effect estimates and 
respective 95% confidence intervals [CIs] arising from the 
most fully adjusted models, and risk estimates by strata of 
interest [eg, cardiac disease, age-group, lag period]).
assessment of risk of bias in individual 
studies
Each individual cohort study was reviewed for study qual-
ity and potential sources of bias by two independent inves-
tigators (KB and JK) using the Newcastle–Ottawa Scale 
for observational studies recommended by the Cochrane 
Collaboration.13,14 Briefly, each included study was rated 
according to three grouping items: selection of cohort, com-
parability of cohort, and assessment of outcome. High-quality 
choices were scored with a star, with a maximum of nine stars 
achievable for all eight subitems (one star for each numbered 
item within the selection and outcome categories; a maximum 
of two stars for comparability). Of note, adjustment for the 
most relevant stroke risk factors (eg, arterial hypertension and 
age), minimum length of follow-up of 10 years, dropout rate 
less than 20%, and exposure, as well as outcome ascertained 
other than self-report (eg, linked primary record sources), 
were considered high-quality choices.
synthesis of results and additional 
analyses
Statistical analyses were performed with the use of the 
software package Stata (Version 12.1; StataCorp, College 
Station, TX, USA) and the user-written package Metan for 
meta-analyses. For simplicity reasons, we reported RR with 
95% CI as the common effect estimate for the association 
between the exposure and the incident cases (hereinafter 
referred to as overall RR). However, to minimize statisti-
cal heterogeneity, the primary and some of the additional 
analyses were carried out separately for studies reporting 
HR and OR/RR. The OR and RR reflect the risk at a given 
time point, and both can be considered interchangeable when 
the absolute number of cases is small (,10%).15 Since the 
event rates were below 10% in the included studies, we 
merged OR and RR for this purpose. The most fully adjusted 
effect estimates from the included studies were combined 
using the DerSimonian and Laird random-effects model.16 
Assuming substantial heterogeneity among a set of large-
scale cohort studies gathered from the published literature, 
this method was chosen a priori, as it cannot be anticipated 
that variation in observed effect estimates is exclusively a 
result of sampling error (that would be the assumption for a 
fixed-effect model).17
A test of between-study statistical heterogeneity was 
performed using the Cochran’s Q statistic (with significant 
heterogeneity set at P,0.1), and the percentage of variation 
across studies attributable to heterogeneity was described with 
the I  2 statistic.18 An I  2 value of 0 indicates no, 25%–50% low, 
50%–75% moderate, and .75% high observed heterogeneity. 
We ascertained potential sources of between-study hetero-
geneity and the robustness of the obtained results by several 
sensitivity and subgroup analyses. Statistical significance 
was set at P,0.05. If an included study reported stratified 
effect estimates, these were pooled using the inverse-variance 
fixed-effect or DerSimonian and Laird random-effects model 
(whichever applicable). We assessed publication bias by 
visual inspection of the funnel plot and the use of Egger’s 
linear regression and Begg’s rank correlation tests.19,20 The 
Duval and Tweedie trim-and-fill method was applied to iden-
tify and adjust for significant small-study effects.21
Results
systematic review
As detailed in the flowchart in Figure 1, a total of 6,090 titles/
abstracts were retrieved from the electronic literature and 62 
from the bibliographies of published literature. Of these, we 
independently reviewed 61 full-text articles for eligibility and 
retained 28 articles for our quantitative data synthesis.4,22–48
Since the previously published meta-analyses cover-
ing a literature search until May 2011,1,2 nine more pub-
lished studies investigating the prospective relationship 
between depression and stroke with 412,699 participants 
and 6,559 incident stroke cases were identified according 
to our eligibility criteria and included in our quantitative 
data synthesis.4,25,26,29,30,34,36,41,42 All included studies were 
designed as prospective community- or population-based 
cohort studies, except two that comprised registry-based 
cohorts.29,42 The total number of participants in the included 
studies was 681,139 with 13,436 (1.97%) incident stroke 
cases observed during a total follow-up ranging from 3 
to 29 years. One study did not report the exact number of 
incident cases.46 Diagnosis of depression was largely based 
on a self-rating depression scale (n=24), with the Center for 
Epidemiological Studies – Depression (CES-D) being the 
most commonly used assessment scale (n=11). In only four   
studies, the baseline depression diagnosis originated from 
a direct evaluation through a psychologist, psychiatrist, or 
other physician according to ICD or DSM criteria.29,34,35,42 Neuropsychiatric Disease and Treatment 2015:11 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
4
Barlinn et al
Records identified through
database searching (n=6,090)
Records identified through
other sources (n=62)
Records after duplicates
removed (n=6,100)
Records screened
(n=6,100)
Records excluded
(n=6,039)
Full-text articles excluded
(n=33)
Stroke or TIA not excluded at baseline
(n=18)
Review, meta-analysis, or no cohort design
(n=7)
Same study population (n=2)
Data not available (n=2) •
•
•
•
•
Exposure not explicitly defined or studied
in relation to the end point of interest (n=4)
Full-text articles
assessed for eligibility
(n=61)
Studies included in
the quantitative
synthesis (n=28)
Figure 1 Flow diagram of study selection for the quantitative data synthesis.
Abbreviation: Tia, transient ischemic attack.
Most of the studies used medical records and death cer-
tificates, to some extent in combination with self- or proxy 
reporting, for the diagnosis of stroke. In only four studies, the 
diagnosis of (nonfatal) stroke solely relied on self- or proxy 
reporting.23,27,30,33 Most studies restricted the end point to isch-
emic and hemorrhagic stroke (n=15),4,23,24,26,28–31,36,37,40,41,44,47,48 
two studies to ischemic stroke and TIA,22,42 and eleven stud-
ies captured all stroke (ischemic, hemorrhagic, and TIA) 
end points.25,27,32–35,38,39,43,45,46 With regard to stroke survival, 
three studies recorded only fatal stroke.24,28,32 Fifteen studies 
excluded participants with cardiac disease at baseline a priori 
or in additional analyses,25,26,28,31,32,34,36–38,41,42,44,46–48 of which 
six had not been included in previous meta-analyses. In 
terms of effect estimates, six studies reported RRs,31,33,35,38,39,47 
19 HRs,4,22–28,32,36,37,40–46,48 and three ORs.29,30,34 A full summary 
of the included studies, with an assessment of study quality 
by the Newcastle–Ottawa Scale, is provided in Table 1.
To minimize the possibility of reverse causality, seven 
studies considered a lag period by excluding the first 
years of follow-up (first 2 years, n=2; first 3 years, n=2; 
first 5 years, n=3),4,24,31,32,36,37,41 and one study considered 
only participants free of cerebrovascular disease who had 
received a depression diagnosis at least 10 years before 
baseline.42 Six studies were primarily conducted in par-
ticipants aged $65 years,22,23,32,35,39,41 and seven studies in 
participants ,65 years.4,26,28,30,36,37,44 The age of participants 
in the remainder of studies overlapped these age strata; 
however, two studies provided additional analyses for effect 
estimates stratified by age (,65 and $65 years).27,43 Three 
studies exclusively reported effect estimates stratified by 
race/sex (white men, white women, black persons) and age 
(,65 and $65 as well as 65–74 and $75 years, respectively) 
strata.23,31,43 From these studies, pooled estimates were used 
for the current analysis. An additional analysis defining Neuropsychiatric Disease and Treatment 2015:11 submit your manuscript | www.dovepress.com
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Depression and stroke
depression in relation to the use of antidepressant medication 
was performed in six of 27 studies.30,37,40–43
Primary quantitative data synthesis
Of the 28 included studies, 15 reported a significant positive 
association between the risk of a first-ever stroke and depres-
sive disorder.4,22,25–27,29–33,35,38,40–42 In ten studies, there was a 
positive association too, though these did not show statistical 
significance in the primary analyses.23,24,28,34,36,39,43–45,47 Pooling 
the risk estimates from all of these 28 studies revealed an 
increased risk of an incident stroke for depression by 40% 
(overall RR 1.40, 95% CI 1.27–1.53; P,0.0001), with an 
I  2 statistic of 49% (P=0.002 by Cochran Q test). This asso-
ciation remained alike when we separately pooled studies 
that reported ORs/RRs (OR/RR 1.54, 95% CI 1.25–1.89; 
P,0.0001; n=9) and HRs (HR 1.34, 95% CI 1.21–1.49; 
P,0.0001; n=19). There was evidence of moderate heteroge-
neity with an I  2 statistic of 67% (P=0.002 by Cochran Q test) 
for studies that reported ORs/RRs, and low heterogeneity 
with an I  2 statistic of 36% (P=0.064 by Cochran Q test) for 
studies that reported HRs. Figure 2 depicts the forest plots for 
the association between depression and incident stroke.
sensitivity and subgroup analyses
In order to minimize the possibility of reverse causality, we 
conducted an additional analysis where we considered stud-
ies that excluded incident strokes that occurred in the first 
years of follow-up separately. Specific data were not avail-
able from two studies.32,37 While five of six studies with data 
available found a significant positive association between 
depression and a first-ever stroke (effect estimates .1.0, 
P,0.005),24,31,36,41,42 one study suggested a reverse causal 
inference for depressive symptoms and stroke after excluding 
the first 5 years of follow-up (HR 0.94, 95% CI 0.64–1.37; 
P=0.74).4 Synthesizing these risk estimates revealed a persis-
tent predictive association between depression and incident 
stroke (overall RR 1.64, 95% CI 1.27–2.11; P,0.0001). 
The heterogeneity was moderate, with an I  2 statistic of 
60% (P=0.03 by Cochran Q test). This association remained 
strong after including only studies that reported HRs (HR 
1.62, 95% CI 1.17–2.23, P=0.003; I  2=66%, P=0.018 by 
Cochran Q; n=5). Figure 3 illustrates the corresponding 
forest plot.
We repeated our primary analysis, but excluded studies 
that enrolled participants with cardiac disease at baseline, 
and still found a strong independent association between 
depression and incident stroke (overall RR 1.43, 95% 
CI 1.19–1.72; P,0.0001), with evidence of moderate 
W
a
s
s
e
r
t
h
e
i
l
-
s
m
o
l
l
e
r
 
e
t
 
a
i
4
7
7
3
,
0
9
8
 
w
o
m
e
n
,
 
5
0
–
7
9
 
y
e
a
r
s
;
 
U
n
i
t
e
d
 
s
t
a
t
e
s
4
.
1
 
y
e
a
r
s
 
(
m
e
a
n
)
,
 
u
n
t
i
l
 
2
0
0
1
6
-
i
t
e
m
 
c
e
s
-
D
 
$
5
F
a
t
a
l
/
n
o
n
f
a
t
a
l
 
i
s
c
h
e
m
i
c
 
a
n
d
 
h
e
m
o
r
r
h
a
g
i
c
 
s
t
r
o
k
e
;
 
s
e
l
f
-
r
e
p
o
r
t
 
a
n
d
 
m
e
d
i
c
a
l
 
r
e
c
o
r
d
s
4
6
4
a
g
e
,
 
r
a
c
e
,
 
e
d
u
c
a
t
i
o
n
,
 
i
n
c
o
m
e
,
 
B
M
i
,
 
c
h
o
l
e
s
t
e
r
o
l
,
 
d
i
a
b
e
t
e
s
,
 
s
m
o
k
i
n
g
,
 
h
o
r
m
o
n
e
 
t
h
e
r
a
p
y
,
 
p
h
y
s
i
c
a
l
 
a
c
t
i
v
i
t
y
,
 
h
y
p
e
r
t
e
n
s
i
o
n
 
s
t
a
t
u
s







W
o
u
t
s
 
e
t
 
a
l
4
8
2
,
9
6
5
 
m
e
n
 
(
4
8
%
)
 
a
n
d
 
w
o
m
e
n
,
 
$
5
5
 
y
e
a
r
s
;
 
N
e
t
h
a
r
l
a
n
d
s
7
.
7
 
y
e
a
r
s
 
(
m
e
a
n
)
,
 
1
9
9
2
–
2
0
0
2
D
i
s
 
(
m
a
j
o
r
 
d
e
p
r
e
s
s
i
o
n
 
a
c
c
o
r
d
i
n
g
 
t
o
 
D
s
M
-
i
i
i
)
F
a
t
a
l
/
n
o
n
f
a
t
a
l
 
i
s
c
h
e
m
i
c
 
a
n
d
 
h
e
m
o
r
r
h
a
g
i
c
1
7
6
a
g
e
,
 
s
e
x
,
 
M
i
n
i
-
M
e
n
t
a
l
 
s
t
a
t
e
 
e
x
a
m
i
n
a
t
i
o
n
 
s
c
o
r
e
,
 
s
m
o
k
i
n
g
,
 
f
u
n
c
t
i
o
n
a
l







N
o
t
e
s
:
 
*
s
t
u
d
y
 
p
o
p
u
l
a
t
i
o
n
 
c
o
m
p
r
i
s
i
n
g
 
s
t
r
o
k
e
-
f
r
e
e
 
i
n
d
i
v
i
d
u
a
l
s
 
w
i
t
h
 
n
o
 
m
i
s
s
i
n
g
 
d
a
t
a
 
o
n
 
t
h
e
 
e
x
p
o
s
u
r
e
 
a
n
d
 
o
u
t
c
o
m
e
 
v
a
r
i
a
b
l
e
s
.
 
T
h
e
 
q
u
a
l
i
t
y
 
o
f
 
e
a
c
h
 
i
n
c
l
u
d
e
d
 
c
o
h
o
r
t
 
s
t
u
d
y
 
w
a
s
 
a
s
s
e
s
s
e
d
 
b
y
 
t
h
e
 
N
e
w
c
a
s
t
l
e
-
O
t
t
a
w
a
 
s
c
a
l
e
.
1
3
 
h
i
g
h
 
q
u
a
l
i
t
y
 
c
h
o
i
c
e
s
 
w
e
r
e
 
s
c
o
r
e
d
 
w
i
t
h
 
a
 
‘
s
t
a
r
’
,
 
w
i
t
h
 
a
 
m
a
x
i
m
u
m
 
o
f
 
n
i
n
e
 
s
t
a
r
s
 
a
c
h
i
e
v
a
b
l
e
 
f
o
r
 
t
h
e
 
t
h
r
e
e
 
g
r
o
u
p
i
n
g
 
i
t
e
m
s
 
(
s
e
l
e
c
t
i
o
n
 
o
f
 
c
o
h
o
r
t
,
 
c
o
m
p
a
r
a
b
i
l
i
t
y
 
o
f
 
c
o
h
o
r
t
 
a
n
d
 
a
s
s
e
s
s
m
e
n
t
 
o
f
 
o
u
t
c
o
m
e
)
.
A
b
b
r
e
v
i
a
t
i
o
n
s
:
 
C
E
S
-
D
,
 
C
e
n
t
e
r
 
f
o
r
 
E
p
i
d
e
m
i
o
l
o
g
i
c
a
l
 
S
t
u
d
i
e
s
 
–
 
D
e
p
r
e
s
s
i
o
n
;
 
G
H
Q
,
 
G
e
n
e
r
a
l
 
H
e
a
l
t
h
 
Q
u
e
s
t
i
o
n
n
a
i
r
e
;
 
H
P
L
,
 
H
u
m
a
n
 
P
o
p
u
l
a
t
i
o
n
 
L
a
b
o
r
a
t
o
r
y
;
 
M
O
P
S
Y
,
 
M
O
N
I
C
A
 
–
 
p
s
y
c
h
o
s
o
c
i
a
l
;
 
I
C
D
,
 
I
n
t
e
r
n
a
t
i
o
n
a
l
 
C
l
a
s
s
i
fi
c
a
t
i
o
n
 
o
f
 
D
i
s
e
a
s
e
s
;
 
G
W
B
-
D
,
 
g
e
n
e
r
a
l
 
W
e
l
l
-
B
e
i
n
g
 
–
 
D
e
p
r
e
s
s
i
o
n
;
 
s
D
s
,
 
s
e
l
f
-
r
a
t
i
n
g
 
D
e
p
r
e
s
s
i
o
n
 
s
c
a
l
e
;
 
D
i
s
,
 
d
i
a
g
n
o
s
t
i
c
 
i
n
t
e
r
v
i
e
w
 
s
c
h
e
d
u
l
e
;
 
D
s
M
,
 
D
i
a
g
n
o
s
t
i
c
 
a
n
d
 
S
t
a
t
i
s
t
i
c
a
l
 
M
a
n
u
a
l
 
o
f
 
M
e
n
t
a
l
 
D
i
s
o
r
d
e
r
s
;
 
B
D
i
,
 
B
e
c
k
 
D
e
p
r
e
s
s
i
o
n
 
i
n
v
e
n
t
o
r
y
;
 
M
h
i
,
 
M
e
n
t
a
l
 
h
e
a
l
t
h
 
i
n
v
e
n
t
o
r
y
;
 
B
M
i
,
 
b
o
d
y
 
m
a
s
s
 
i
n
d
e
x
.Neuropsychiatric Disease and Treatment 2015:11 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
10
Barlinn et al
heterogeneity (I  2=58%, P=0.003 by Cochran Q test). 
Analyzing studies by preferred reported risk estimates did 
not change the results. The pooled OR/RR was 1.42 (95% 
CI 1.03–1.96, P,0.034; n=4), and the pooled HR was 1.45 
(95% CI 1.13–1.85, P,0.003; n=11), both with evidence 
of moderate heterogeneity (I  2=67%, P=0.027 by Cochran 
Q, and I  2=58%, P=0.008 by Cochran Q, respectively). The 
exclusion of studies that focused on either fatal or nonfatal 
strokes did not alter the results either (overall RR 1.36, 95% 
CI 1.24–1.50, P,0.0001; I  2=46%, P=0.007 by Cochran Q). 
A strong prospective association between depression and 
incidence of a first-ever stroke remained after focusing on 
studies that assessed all stroke subtypes (ie, ischemic and 
hemorrhagic stroke, TIA) as the outcome measure (overall 
RR 1.50, 95% CI 1.21–1.86, P,0.0001; I  2=62%, P=0.004 
by Cochran Q). To minimize misclassification bias, we 
removed studies that primarily defined the exposure variable 
by self-reporting, and found a slightly higher risk of incident 
stroke for clinically diagnosed depression at baseline (overall 
RR 1.64, 95% CI 1.21–2.24, P=0.002; I  2=68%, P=0.015 by 
Cochran Q). Similar results to those obtained by the primary 
analysis were found when restricting the data synthesis to 
a minimum cohort size of 5,000 participants (overall RR 
1.33, 95% CI 1.23–1.44, P,0.0001; I  2=35%, P=0.076 by 
Cochran Q) and a minimum duration of follow-up of 5 years 
(overall RR 1.41, 95% CI 1.27–1.56, P,0.0001; I  2=42%, 
P=0.018 by Cochran Q). Excluding the two registry-based 
cohort studies from the primary analysis did not change 
the results (overall RR 1.40, 95% CI 1.26–1.55, P,0.001; 
I  2=48%, P=0.004 by Cochran Q).
When we stratified the included studies by age, it appeared 
that the $65-year (overall RR 1.45, 95% CI 1.20–1.75, 
P,0.0001; I  2=55%, P=0.029 by Cochran Q) age-group had a 
slightly lower risk than the ,65-year (overall RR 1.59, 95% CI 
1.35–2.09, P,0.0001; I  2=52%, P=0.035 by Cochran Q) age-
group. Extending the definition of depression to the additional 
or exclusive use of antidepressants resulted in an elevation 
of the prospective risk of stroke (overall RR 1.60, 95% CI 
1.23–2.09, P,0.0001; I  2=64%, P=0.026 by Cochran Q).
Publication bias
The funnel plot appeared slightly asymmetric, with evi-
dence of small-study effects (ie, tendency that smaller 
studies show larger treatment effects) demonstrated by both 
Study
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Begg’s (z=1.78, P=0.075) and Egger’s (P=0.013) tests. We 
conducted a sensitivity analysis where we imputed eight 
theoretically missing studies in our meta-analysis using 
Duval and Tweedie’s trim-and-fill method. The recalculation 
of the pooled effect estimate revealed a slightly attenuated 
but still significantly increased risk of incident stroke for 
depression (overall RR 1.26, 95% CI 1.14–1.40; P,0.0001). 
There was no evidence of significant publication bias for 
studies that reported HR (Begg’s P=0.35, Egger’s P=0.17) 
and substantial evidence of bias for studies that reported OR/
RR (P=0.026 by Egger’s test). However, the latter studies 
still yielded a significant association after adjusting for small-
study effects (OR/RR 1.27, 95% CI 1.03–1.56; P=0.026).
Discussion
The major finding of this meta-analysis comprising almost 
700,000 participants, consistent with previous analyses, is 
that depression increases the risk of first-ever stroke by 40% 
in the general population. Moreover, our results relating 
depression to incident stroke are corroborated by recently 
published similar pooled estimates with an increased overall 
risk of stroke (34% and 45%, respectively), yet we included 
nine new studies, adding more than 400,000 participants.1,2 
This prospective association appears to be driven neither by 
the preexistence of clinically apparent cerebro- and cardio-
vascular disease nor by silent stroke.
While our synthesized results suggest a possible causal 
association between depression and stroke, recently analyzed 
data from a large prospective cohort study contradict this 
contention by showing a nullified incident risk of stroke once 
a different analytic approach was applied.4 In this study, the 
risk of incident stroke was significantly elevated by 60% for 
depressed individuals, yet no such association was evident 
with exclusion of incident events that occurred in the first 
5 years of follow-up. This analytic “lag period” approach 
was chosen to avoid the impact of possible reverse causal-
ity between preexisting silent cerebrovascular disease and 
depression, based on the vascular depression concept.49,50 
However, this cohort study was limited by the absence of 
adjustment for vascular risk factors, use of a nonspecific 
depression screening scale, and an upper age limit of study 
participants of 55 years.4 In contrast, several previous cohort 
studies did not show significant influence of a lag period on 
the prospective association between the risk of incident stroke 
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and depression.24,31,36,41,42 This is also reflected by the results 
of our synthesized subanalysis on studies that accounted 
for residual confounding by excluding the initial follow-up 
period showing a nearly identical overall (41%) and even 
pronounced risk once a lag period was defined, as opposed to 
studies with no lag period (64% and 34%, respectively). Also, 
the fact that most studies we included in our meta-analysis 
adjusted properly for well-established vascular risk factors 
further substantiates the notion that the association between 
depression and stroke could be independent of coexisting 
vascular diseases.
In concordance with the original vascular depression 
concept, which specifically proposed an association between 
cerebral small-vessel disease and depression in the elderly, 
a recent meta-analysis confirmed cerebral small-vessel dis-
ease being fourfold more common in patients with late- than 
early onset depression.3,51 Another more recent meta-analysis 
on this subject reported similar though weaker results.52 
However, the development of cerebral small-vessel disease 
increases with age and is related to an increased risk of 
stroke.9 Therefore, viewed in conjunction with the vascular 
depression concept, it could be anticipated that particularly 
the elderly suffering from depression have an increased risk of 
stroke. Still, we found a balanced risk of stroke across groups 
stratified by age (even slightly lower in absolute numbers for 
the $65-year than the ,65-year age-group), and one study 
included in our meta-analysis even suggested a higher risk 
of stroke in younger people with depression.43 Specifically, 
data originating from the Framingham Heart Study showed 
that depressive symptoms were significantly associated with 
a fourfold-increased risk of a first-ever ischemic stroke in 
individuals younger than 65 years but not in those older than 
or equal to 65 years. This discrepancy of balanced (or even 
increased) risk of stroke in younger depressed individuals and 
the increasing risk of stroke with age in the general popula-
tion may be partially explained by the fact that depressive 
individuals less commonly adhere to medication than nonde-
pressed people, and consequently primary stroke prevention 
may be compromised in depressed individuals.53,54 Moreover, 
unhealthy lifestyle, including smoking, unfavorable food, and 
lack of physical activity, is also associated with depression 
and in turn an increased risk of stroke.55–59
Consistent with our finding of a balanced risk of stroke 
between young and elderly individuals with depression, a 
previous systematic review of 23 etiological, phenomeno-
logical, and outcome studies did not find any identifiable 
distinguishing clinical features between early onset and 
late-onset depression.60 Additionally, it might be speculated 
that an increased stroke risk in depressed people may arise 
from pharmacological interferences with platelet aggrega-
tion, as recently discussed for antidepressant medication and 
even suggested by the increased stroke risk (60%) yielded 
from our subanalysis of six studies that defined depression 
in relation to the use of antidepressant medication.61 On 
the other hand, a recent study did not confirm an increased 
risk of stroke in individuals with manic or bipolar disorder, 
a mental illness also known to be associated with unhealthy 
lifestyle behavior and a pronounced burden of vascular risk 
factors.62–64 This dissonant increase of stroke risk in depressed 
but not manic or bipolar individuals might suggest that the 
underlying cerebral pathomechanisms might be specific for 
depression. Based on the findings of previous studies, these 
mechanisms might include cerebral inflammation, dysregula-
tion of the hypothalamic–pituitary–adrenal axis, increased 
platelet reactivity, and autonomic dysfunction.65
Our quantitative data synthesis is subject to limitations, 
mostly associated with clinical and methodological diver-
sity among the included studies, as shown by the moderate 
heterogeneity in our pooled data set. Clinical heterogeneity 
is given by the variety of self-reporting mood scales used in 
the studies included in our analysis, potentially introducing 
misclassification and information bias. This may particularly 
apply to participants prescribed antidepressant medication 
possibly obscuring the actual prevalence of depression at 
baseline. Another shortcoming relates to the fact that most 
of the published studies defined the outcome measures as 
any stroke subtype instead of focusing on a specific subtype 
(eg, ischemic or hemorrhagic stroke) or etiology. There-
fore, stroke subtype- or etiology-specific differences in the 
relationship between depression and stroke might remain 
undetected in our synthesized analysis. Particularly given that 
in young adults, causes of stroke are less frequently attributed 
to cerebrovascular diseases compared with the elderly, but 
comprise a broad spectrum of nonatherosclerotic causes (eg, 
arterial dissection, hypercoagulable state, nonatherosclerotic 
arteriopathies, or cryptogenic), our finding of balanced 
stroke risk in different age-groups must be considered with 
caution.66 This also relates to hemorrhagic stroke, which has 
a variety of underlying age-dependent etiologies itself.
Even though we excluded studies that had enrolled 
participants with a known history of stroke in order to mini-
mize confounding effects arising from potential preexisting 
cerebrovascular disease, it remains speculative to what extent 
unknown subclinical cerebrovascular disease might have 
influenced stroke risk in our analysis. Many studies, however, 
have consistently shown that particularly severe strokes with Neuropsychiatric Disease and Treatment 2015:11 submit your manuscript | www.dovepress.com
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prominent functional disability predict the development of 
depression.5,67 Conversely, it might be speculated that stroke 
survivors clinically less severely affected may have a lower, 
if any, risk of developing a depression. Nevertheless, we 
reduced the probability of coexisting undetected cerebrovas-
cular disease by performing a sensitivity analysis, removing 
studies that included patients with a history of cardiac disease, 
and yielded similar results.
Conclusion
Whether the consistent association of depression and 
increased risk of first-ever stroke demonstrated in this meta-
analysis is indicative of depression-induced neurovascular 
pathology or is rather attributed to an interplay between 
two mutually enhancing conditions needs to be further 
elucidated in long-term studies. These studies should focus 
on specific stroke subtypes and preferably enroll young 
individuals free of cerebrovascular and cardiovascular 
diseases and provide longitudinal cerebral structural and 
functional assessment.
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